Other
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Abstract
Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory...
Paper Details
Title
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Published Date
Aug 17, 2017
Journal
Volume
1
Issue
19
Pages
1533 - 1536
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History